Literature DB >> 8153874

Complement deficiency and immune complex disease.

K A Davies1, J A Schifferli, M J Walport.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8153874     DOI： 10.1007/bf01837367

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  116 in total

1.  The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Authors:  R A NELSON
Journal:  Science       Date:  1953-12-18       Impact factor: 47.728

2.  The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.

Authors:  J A Schifferli; Y C Ng; J Estreicher; M J Walport
Journal:  J Immunol       Date:  1988-02-01       Impact factor: 5.422

3.  Combined homozygous factor H and heterozygous C2 deficiency in an Italian family.

Authors:  M Brai; G Misiano; S Maringhini; I Cutaja; G Hauptmann
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

4.  Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies.

Authors:  T T Provost; F C Arnett; M Reichlin
Journal:  Arthritis Rheum       Date:  1983-10

5.  The role of C1, C1-inactivator and C4 in modulating immune precipitation.

Authors:  J A Schifferli; G Steiger; M Schapira
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

6.  Density separation of human red blood cells on self forming Percoll gradients: correlation with cell age.

Authors:  H U Lutz; P Stammler; S Fasler; M Ingold; J Fehr
Journal:  Biochim Biophys Acta       Date:  1992-03-05

7.  Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.

Authors:  O Meyer; G Hauptmann; G Tappeiner; H D Ochs; F Mascart-Lemone
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

8.  Inhibition of immune precipitation by complement.

Authors:  K Hong; Y Takata; K Sayama; H Kozono; J Takeda; Y Nakano; T Kinoshita; K Inoue
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

9.  Complement-mediated adherence of immune complexes to human erythrocytes. Difference in the requirements for C4A and C4B.

Authors:  J A Schifferli; G Hauptmann; J P Paccaud
Journal:  FEBS Lett       Date:  1987-03-23       Impact factor: 4.124

10.  Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).

Authors:  N Madi; J P Paccaud; G Steiger; J A Schifferli
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330
View more
  20 in total

1.  Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.

Authors:  M Boes; T Schmidt; K Linkemann; B C Beaudette; A Marshak-Rothstein; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Genetic susceptibility to lupus: the biological basis of genetic risk found in B cell signaling pathways.

Authors:  Samuel E Vaughn; Leah C Kottyan; Melissa E Munroe; John B Harley
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 3.  The complement system: history, pathways, cascade and inhibitors.

Authors:  P N Nesargikar; B Spiller; R Chavez
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

Review 4.  Apoptosis and autoimmunity: complement deficiency and systemic lupus erythematosus revisited.

Authors:  J S Navratil; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

5.  Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity.

Authors:  Georgia Sfyroera; Daniel Ricklin; Edimara S Reis; Hui Chen; Emilia L Wu; Yiannis N Kaznessis; Kristina N Ekdahl; Bo Nilsson; John D Lambris
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

Review 6.  Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.

Authors:  Dimitrios C Mastellos; Despina Yancopoulou; Petros Kokkinos; Markus Huber-Lang; George Hajishengallis; Ali R Biglarnia; Florea Lupu; Bo Nilsson; Antonio M Risitano; Daniel Ricklin; John D Lambris
Journal:  Eur J Clin Invest       Date:  2015-03-09       Impact factor: 4.686

7.  Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus.

Authors:  Celene M O S Alves; Cleni M Marzocchi-Machado; Paulo Louzada-Junior; Ana Elisa C S Azzolini; Ana Cristina M Polizello; Ivan F de Carvalho; Yara M Lucisano-Valim
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

8.  Nonsense-codon-mediated decay in human hereditary complement C3 deficiency.

Authors:  Edimara S Reis; Victor Nudelman; Lourdes Isaac
Journal:  Immunogenetics       Date:  2003-11-25       Impact factor: 2.846

9.  C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection.

Authors:  Yumi Nakayama; Shin-Il Kim; Eui Ho Kim; John D Lambris; Matyas Sandor; M Suresh
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

Review 10.  New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.

Authors:  V Michael Holers; Stephen Tomlinson; Liudmila Kulik; Carl Atkinson; Bärbel Rohrer; Nirmal Banda; Joshua M Thurman
Journal:  Semin Immunol       Date:  2016-06-06       Impact factor: 11.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.